Redhill Biopharma Ltd.-SP ADRRDHL
13F holders, Q1 2025 (March 31)12holders +1
2new positions
1sold out
1famous investor
$2.66avg. 13F price*
At the end of Q1 2025, 12 institutions reported holding Redhill Biopharma Ltd.-SP ADR (RDHL) in their 13F filings, up 1 from Q4 2024. 2 opened new positions and 1 sold out. The largest holders were Citadel Advisors ($57K), GAMMA Investing LLC ($9K) and Federation des caisses Desjardins du Quebec ($9K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Redhill Biopharma Ltd.-SP ADR
- CUSIP
- 757468301
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $57K |
| Exits | 1 | $2K |
All 13F filers, Q4 2024 → Q1 2025: 22,053 shares bought and 8,481 shares sold, net +13,572 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Citadel Advisors | 0.00% | New | 21,512 | $57K |
| GAMMA Investing LLC | 0.00% | Reduce -29.9% | 3,568 | $9K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 3,388 | $9K |
| Rhumbline Advisers | 0.00% | Add +15.9% | 1,388 | $4K |
| Bank of America Corp. | 0.00% | Add +15050.0% | 303 | $806 |
| Financial Management Professionals, Inc. | 0.00% | New | 47 | $125 |
| Group One Trading LLC | 0.00% | No change | 22 | $59 |
| Morgan Stanley | 0.00% | Reduce -99.4% | 13 | $34 |
| SBI Securities Co., Ltd. | 0.00% | Add +150.0% | 5 | $13 |
| UBS Group AG | 0.00% | Reduce -99.9% | 3 | $8 |
| Vermillion Wealth Management, Inc. | 0.00% | No change | 2 | $5 |
| Royal Bank of Canada | 0.00% | No change | 4 | $0 |
"% of holder's portfolio" is RDHL's weight in each manager's 13F, not the share of Redhill Biopharma Ltd.-SP ADR the manager owns.